Evome Medical Technologies (Evome Medical Technologies) EV-to-FCF : -34.20 (As of May. 17, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Evome Medical Technologies's Enterprise Value is $28.39 Mil. Evome Medical Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.83 Mil. Therefore, Evome Medical Technologies's EV-to-FCF for today is -34.20.

The historical rank and industry rank for Evome Medical Technologies's EV-to-FCF or its related term are showing as below:

LNDZF' s EV-to-FCF Range Over the Past 10 Years
Min: -288.84 Med: -1.63 Max: 26.48
Current: -34.55

During the past 11 years, the highest EV-to-FCF of Evome Medical Technologies was 26.48. The lowest was -288.84. And the median was -1.63.

LNDZF's EV-to-FCF is ranked worse than
100% of 364 companies
in the Medical Devices & Instruments industry
Industry Median: 27.94 vs LNDZF: -34.55

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-17), Evome Medical Technologies's stock price is $0.21. Evome Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.174. Therefore, Evome Medical Technologies's PE Ratio for today is At Loss.

Evome Medical Technologies EV-to-FCF Historical Data

The historical data trend for Evome Medical Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies EV-to-FCF Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

EV-to-FCF

Get a 7-Day Free Trial

-0.78

20.96

0.55

-8.83

-36.14

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
EV-to-FCF	Get a 7-Day Free Trial															-16.21	-23.79	-21.08	-32.53	-36.14

Competitive Comparison of Evome Medical Technologies's EV-to-FCF

For the Medical Devices subindustry, Evome Medical Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evome Medical Technologies's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's EV-to-FCF falls into.

Evome Medical Technologies EV-to-FCF Calculation

Evome Medical Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF	=	Enterprise Value (Today)	/	Free Cash Flow (TTM)
	=	28.388	/	-0.83
	=	-34.20

Evome Medical Technologies's current Enterprise Value is $28.39 Mil.
Evome Medical Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.83 Mil.

Evome Medical Technologies (OTCPK:LNDZF) EV-to-FCF Explanation

Evome Medical Technologies's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.21	/	-0.174
	=	At Loss

Evome Medical Technologies's share price for today is $0.21.
Evome Medical Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.174.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Evome Medical Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.